Descrizione

Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.

Figure 140

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 140: Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles." />
  <figcaption>Figure 140. Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Evidenze correlate

CBD per Insonnia

Grado A · 103 studi